17.12.2012 Views

crc press - E-Lib FK UWKS

crc press - E-Lib FK UWKS

crc press - E-Lib FK UWKS

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Toxicity and Side Effects of Cell-Penetrating Peptides 247<br />

as a typical amino acid motif which is presumably of similar function as that for<br />

CPPs. In addition, CPPs usually have a hydrophobic part that is suggested to induce<br />

integration of peptides into the cell membrane. 10 Some CPPs are amphipathic; like<br />

antimicrobial peptides, they adopt an α-helical structure under membrane-mimicking<br />

conditions. 11<br />

The toxicity and cell-lytic activity of antimicrobial peptides necessitate studies<br />

of CPPs’ toxicity on plasma membranes and on general cellular level since similarities<br />

exist between these two classes of peptides. CPPs may act like toxic agents or<br />

peptides on proteins and lipids of cellular membranes, on cell proliferation, and also<br />

in vivo, causing cell death and inflammatory response. Further, some CPPs are<br />

derived from biologically active proteins, so the activities of these peptides must be<br />

evaluated before using them as carriers. Next we describe the most commonly used<br />

methods for assaying in vitro toxicity of different CPPs.<br />

11.2.1 IN VITRO TOXICITY<br />

The term cytotoxicity denotes a complex process spanning from the death of a single<br />

cell (general cytotoxicity) to the altering and gradual malfunction of the target<br />

cell/tissue (organ/cell-specific cytotoxicity). For evaluating short-term effects of<br />

bioactive compounds, a diversity of in vitro cell viability and cytotoxicity assays<br />

has been developed. These in vitro treatments are cheaper, easier to quantify, and<br />

ethically more acceptable than in vivo experiments. 12<br />

On the other hand, in vitro toxicity assays suffer from inherent limitations. In<br />

cell cultures it is usually difficult to recapitulate the respective in vivo situation with<br />

its complex pharmacokinetics. In general, significant differences often exist in drug<br />

exposure and concentration, metabolism, and excretion between in vitro and in vivo<br />

situations. Furthermore, only metabolism in the liver turns some substances toxic,<br />

which can be difficult to model in cell cultures. Analogously, the detoxification<br />

process that converts substances toxic to cells in culture into nontoxic ones for a<br />

living animal can be difficult to recreate in vitro. However, for initial testing of<br />

cytotoxicity, in vitro methods are very useful and informative, especially when<br />

studying compounds with putative membrane activity. In vitro toxicity assays track<br />

changes in cellular homeostasis triggered by the compounds of interest by estimating<br />

their general cytotoxicity or effect on cell viability and assessing integrity of the<br />

plasma membrane or metabolic activity, respectively.<br />

11.2.1.1 Cell Membrane Permeability<br />

The cell plasma membrane, a lipid bilayer, constitutes the first barrier against toxic<br />

agents, preventing hydrophilic molecules from entering the cell. The cellular homeostasis<br />

of ions and organic molecules is regulated at the plasma membrane with help<br />

from specific integral and peripheral proteins embedded in the lipid bilayer, i.e.,<br />

transporters, receptors, channels, and pumps. Small and lipophilic substances are<br />

not hindered by the barrier and diffuse passively through the membrane.<br />

There are several ways in which toxic agents may change the cellular membrane<br />

permeability. They may interfere with the functioning of membrane proteins, for

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!